Please use this identifier to cite or link to this item:
|Title:||Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines.|
|Authors:||Chen, Weisan;McCluskey, James|
|Affiliation:||T Cell Laboratory, Ludwig Institute for Cancer Research, Austin Health, Heidelberg, VIC 3084, Australia.|
|Citation:||Advances in Cancer Research; 95(): 203-47|
|Abstract:||The focusing of cellular immunity toward one, or just a few, antigenic determinant, even during immune responses to complex microorganisms or antigens, is known as immunodominance. Although described in many systems, the mechanisms of determinant immunodominance are only just beginning to be appreciated, especially in relation to the interplay between T cells of differing specificities and the interactions between T cells and the antigen-presenting cells (APCs). The outcome of these cellular interactions can lead to a form of immune suppression of one specificity by another-described as "immunodomination". The specific and detailed mechanisms involved in this process are now partly defined. A full understanding of all the factors that control immunodominance and influence immunodomination will help us to develop better viral and cancer vaccines.|
|Internal ID Number:||16860659|
Cancer Vaccines.genetics.therapeutic use
Major Histocompatibility Complex
Neoplasms.prevention & control.therapy
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.